~," The relative DNA content in 56 human intracranial tumors was investigated by flow cytometry and correlated to their histological type. Tumors with a modal DNA content within the diploid value (2c) 4-l/2c were divided from those with heteroploidy. Of the "benign non-neuroepithelial tumors," the meningiomas (five), neurilemomas (two), pituitary adenomas (three), and one hemangioblastoma had a unimodal diploid/neardiploid DNA content. The "malignant non-neuroepithelial tumors" were both heteroploid (two metastatic carcinomas) and d~lploid/near-diploid (three meningeal fibrosarcomas and one primary malignant lymphoma). Of the neuroepithelial tumors, the highly differentiated gliomas all had a diploid/near-diploid DNA mode except one recurrent oligodendroglioma. The majoril~S, of the poorly differentiated gliomas also presented near-diploid DNA modes. Heteroploidy of primary brain tumors was not correlated with a more malignant clinical/biological behavior in the individuals in this study.
T
HE prognosis in intracranial neoplasms varies with the histological type of tumor and even within subgroups of histogenetically uniform tumors. ~,ls,le,17 In order to obtain a better understanding of the biological behavior of brain tumors, histological examination should be combined with other, complementary, methods. Measurements of nuclear DNA content in tumors is one such method. A large amount of information has been gathered by microphotometric measurements on human extracranial tumors? ,~ However, there are relatively few investigations on intracranial neoplasms by this method. Flow cytometry is a rapid method for studying the ploidy of normal and neoplastic tissues? ,8a8 Recently, there have been some reports on the application of flow cytometry in neuropathology, 7-1~ showing a high number of aneuploid and polyploid stem lines in malignant gliomas. In order to extend these investigations, we studied the relative DNA content and distribution pattern in human intracranial neoplasms, correlated with histology and clinical course.
Materials and Methods
The material consisted of tissue obtained by craniatomy and subsequent biopsy or major surgery in 56 patients with signs of intracranial tumor during an 18-month period (February, 1975 , to August, 1976 . Operations were performed at the Neurosurgical Departments at Ullevaal, Oslo City Hospital, University of Oslo (two patients) and at Rikshospitalet, University of Oslo (54 patients). Clinical records and information from the Norwegian Cancer Registry and the Central Bureau of Statistics were available in all cases. The follow-up period for this study was discontinued in May, 1979.
Flow Cytometry
The material was selected from the same tissue specimen from which frozen sections and paraffinembedded sections for diagnostic purposes were made. The tumor tissue was cut into small pieces and stirred in a spinner flask at 37~ with 0.25% trypsin* in phosphate-buffered saline for 30 minutes. After inactivating the tryptic action with medium (EagleDulbecco supplemented with 10% newborn calf serum),t the cell suspension was repeatedly pipetted *Trypsin obtained from Difco Laboratories, Detroit, Michigan.
tCalf serum obtained from Flow Laboratories, Glasgow, Scotland.
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(to obtain a single-cell suspension), centrifuged and washed twice in 0.9% NaC1, fixed in ice-cold absolute ethanol, and stored at 4~ The cells were treated with 0.5% pepsin and 0.1% ribonuclease solution:~ for 1 hour at 37~ and stained with ethidium bromide for flow cytometric analyses? , 6 The relative cellular DNA content was measured with a cytofluorograph.w The histograms represent counts on about 1.5 • 104 cells per sample. Human lymphocytes were used as control value for diploid (2c) level. A DNA mode within the range of 2c + V2c was considered "near-diploid."
Results

Patient Population
The age distribution of the 56 patients with intracranial neoplasms and their histological classification is presented in Table 1 . There were 20 males and 19 females in the neuroepithelial tumor group, and 10 males and seven females among the rest.
Tumor Classification
The material was divided into two groups according to the DNA distribution pattern of the tumor cells; those with a diploid or near-diploid mode in one, and those with heteroploidy in another ( Table 2) .
Benign Non-neuroepithelial Tumors. A diploid or near-diploid DNA mode was present in the five meningiomas, two neurilemomas, three pituitary adenomas, and the single hemangioblastoma studied (Fig. 1) .
Malignant Non-neuroepithelial Tumors. fibrosarcoma of the meninges. The two other meningeal fibrosarcomas and one primary malignant lymphoma (reticulum cell sarcoma-microglioma) also exhibited a near-diploid modal DNA content. A heteroploid pattern was also present in the second case (MB 10) of brain metastasis from carcinoma.
Highly Differentiated Gliomas. All highly differentiated gliomas studied had a diploid or near-diploid DNA mode, such as seen in Fig. 3 . The only exception was a recurrent oligodendroglioma irradiated postoperatively 6 years before the present craniotomy (Fig. 4) . The histological pattern in the primary biopsy was identical to that in the recurrence, with relatively uniform oligodendroglial cells with dark nuclei of slightly varying size and shape and frequent mitoses and necrosis.
Poorly Differentiated Gliomas. Twenty of the anaplastic gliomas had a near-diploid modal DNA content, and three were heteroploid (Fig. 5) . Medulloblastoma, considered a poorly differentiated or embryonal tumor, was studied in two cases. Both had a near-diploid mode (Fig. 6 ).
Clinicopathological Survival Data
All patients with "benign" tumors are still living, except one, a 30-year-old man who died of a myocardial infarction on the 2nd day after craniotomy.
Of the histologically "malignant" tumors, two patients were living at the end of the observation period. A 42-year-old man with a primary malignant lymphoma (reticulosarcoma-microglioma) located in the left temporal lobe was alive 31/2 years after craniotomy with resection of the left temporal lobe. The other was a 13-year-old boy with a well demarcated meningeal sarcoma located parasagittally in the left parietal region, who was alive 3 years and 8 months after surgical treatment. The two other patients with sarcoma died 121/2 and 58 months after primary therapy, respectively. One of the metastatic carcinomas was in a 37-yearold woman who had had a mastectomy for mammary duct carcinoma 4 years prior to craniotomy. She died of carcinomatosis 23 months after the craniotomy. The second brain metastasis (MB 38) in this series, was found in a 42-year-old man who died 14 days after craniotomy for multiple intracranial metastases from a symptomatic lung carcinoma.
The neuroepithelial tumors are detailed in Tables 3  and 4 . Of the patients living at the end of the follow-up period, six had an astroeytoma, one an ependymoma, and one a plexus papilloma. All of the patients with oligodendroglioma, medulloblastoma, and glioblastoma died during the observation period.
The cases are summarized in Table 5 . The low age at diagnosis in the astrocytoma group is due to the fact that five of nine tumors were located in the posterior fossa, where astrocytomas predominantly occur in younger people. Table 6 shows clinicopathological correlations in near-diploid and heteroploid glioblastomas. The postoperative survival in patients with heteroploid tumors was the longest, the mean survival time being 15 months as compared to 9 months in patients with near-diploid tumors. The median survival differed from eight in near-diploid to 20 months in heteroploid glioblastomas, as seen in Table 6 . This difference was statistically not significant.
Discussion
In contrast to other reports, 7,9,'~ a larger number of poorly differentiated gliomas with a near-diploid DNA mode was found in this study. Hoshino, et al., 9 found a wide distribution of nuclear DNA complement in malignant gliomas. They studied multiple regions within single tumors and found areas where the nuclear population seemed to be primarily diploid, while in other regions the nuclei were tetraploid (4c). In the present study we prepared one single sample from a representative region of each tumor. Because of the nuclear pleomorphism in malignant gliomas, one would expect a high degree of irregularity of DNA content. However, nuclei may vary in size and shape but still have a uniform DNA content. Pfitzer and Pape 15 observed that the size of diploid nuclei in an epidermoid carcinoma varied from 40 to 160 sq #. Levi, et al., ~ reported on the lack of correlation between nuclear size and ploidy.
The pepsin treatment used in the present study converts multinucleated cells into single nuclei. This reported that of 46 malignant brain tumors, the cells were predominantly hyperdiploid in 35 cases, and a lower proportion showed polyploid or aneuploid DNA content. The coefficient of variation was rather high, although not as high as in microspectrophotometric investigations. Nonspecific staining of cell components other than DNA cannot be excluded. A general problem with use of high coefficient of variation is that small cell populations with slightly differing DNA content will not be detected.
The present study confirms that most of the malignant intracranial neoplasms have a modal DNA content near the diploid value. However, a precise identification of tumors with aberrations in a few chromosomes would require a resolution of magnitude + 1% coefficient of variation.
It is interesting that the "benign" non-neuroepithelial tumors as well as the highly differentiated gliomas all had a diploid or near-diploid modal DNA content. The single exception was a recurrent oligodendroglioma. The identical morphology of the tumor tissue removed from the latter on the two occasions may mean that the heteroploidy is a primary quality of this oligodendroglioma. However, it is not known with certainty whether the heteroploidy is intrinsic, or whether it developed after the postoperative radiation therapy.
The heteroploidy of the metastatic carcinomas is consistent with the frequent irregularities of the DNA distribution pattern in the end stages of neoplastic disease? The near-diploid modal DNA content in the primary malignant lymphoma fits well with the observations of Frederiksen, et al./ and Kawamoto, et al? ~ The two medulloblastomas were clearly composed of cells with a unimodal and near-diploid DNA distribution pattern. It is interesting that rapidly growing, highly malignant and anaplastic tumors may show no obvious or only slight alteration of DNA mode. Apparently, the ability to proliferate rapidly and malignant biological behavior is perfectly compatible with a diploid or near-diploid DNA mode in the tumor cell population.
In our material, the prognosis in malignant gliomas with a near-diploid or an aneuploid DNA content was not significantly different. The latter has often been taken as an indication of poor prognosis. Recently, Atkin and Kay x tried to relate survival to DNA measurements in 1465 cases of malignant tumors studied by microspectrophotometry. Intracranial lesions were not presented. They found no conclusive support for the suggestion that diploid or near-diploid tumors have a different prognosis from that of tumors with heteroploid modal DNA content. In accordance with this we conclude that, in the individuals in this study, heteroploidy of primary brain tumors was not correlated to a shorter survival of the patient.
